Skip to content
2000
Volume 22, Issue 8
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

Introduction

Cerebral Amyloid Angiopathy (CAA) is a common form of cerebral small vessel disease (CSVD), characterized by the accumulation of amyloid-β (Aβ) protein in the walls of cortical and leptomeningeal arteries and arterioles. The sporadic form primarily affects the elderly and is closely associated with Alzheimer’s disease (AD). Despite previous studies on cognition, the specific neuropsychological profile of CAA remains unclear. This study aims to describe the cognitive profile of CAA patients and characterize their neuropsychological aspects in the absence of a clinical diagnosis of AD.

Methods

We present a case series of six patients with probable CAA, without clinical evidence of AD, who underwent extensive neuropsychological assessment. Additionally, a narrative review was conducted to synthesize current knowledge of the cognitive and neuropsychological aspects of sporadic CAA.

Results

The narrative review indicates that CAA predominantly affects executive functioning, processing speed, episodic memory, global cognition, and visuospatial functions. In our case series, all patients exhibited impairments in these domains, except for global cognition. Notably, a specific dissociation was observed in the Rey Auditory Verbal Learning Test (RAVLT), with impaired delayed recall but preserved recognition.

Discussion

Sporadic CAA in patients without AD contributes to cognitive impairment, particularly affecting executive functioning, processing speed, visuospatial functions, and episodic memory. In our sample, memory impairment in CAA follows a dysexecutive pattern, characterized by retrieval deficits with preserved storage. This contrasts with the amnestic profile seen in AD and amnestic mild cognitive impairment (aMCI), where both retrieval and storage are compromised.

Conclusion

This distinct memory profile may represent a useful neuropsychological marker for differentiating CAA-related cognitive impairment from that associated with AD and its prodromal forms. This differentiation has potential implications for diagnosis, prognosis, and the development of tailored therapeutic strategies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050390451250808002719
2025-08-18
2025-12-25

  • From This Site

    /content/journals/car/10.2174/0115672050390451250808002719
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PantoniL. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges.Lancet Neurol.20109768970110.1016/S1474‑4422(10)70104‑620610345
     [Google Scholar]
  2. CozzaM. AmadoriL. BoccardiV. Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment.J. Neurol. Sci.2023454812086610.1016/j.jns.2023.12086637931443
     [Google Scholar]
  3. ViswanathanA. GreenbergS.M. Cerebral amyloid angiopathy in the elderly.Ann. Neurol.201170687188010.1002/ana.2251622190361
     [Google Scholar]
  4. JäkelL. De KortA.M. KlijnC.J.M. SchreuderF.H.B.M. VerbeekM.M. Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis.Alzheimers Dement.2022181102810.1002/alz.1236634057813
     [Google Scholar]
  5. CharidimouA. BoulouisG. FroschM.P. The Boston criteria version 2.0 for cerebral amyloid angiopathy: A multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.Lancet Neurol.202221871472510.1016/S1474‑4422(22)00208‑335841910
     [Google Scholar]
  6. MalhotraK. TheodorouA. KatsanosA.H. Prevalence of clinical and neuroimaging markers in cerebral amyloid angiopathy: A systematic review and meta-analysis.Stroke20225361944195310.1161/STROKEAHA.121.03583635264008
     [Google Scholar]
  7. WermerM.J.H. GreenbergS.M. The growing clinical spectrum of cerebral amyloid angiopathy.Curr. Opin. Neurol.2018311283510.1097/WCO.000000000000051029120920
     [Google Scholar]
  8. GreenbergS.M. VonsattelJ.P.G. StakesJ.W. GruberM. FinklesteinS.P. The clinical spectrum of cerebral amyloid angiopathy.Neurology199343102073207910.1212/WNL.43.10.20738413970
     [Google Scholar]
  9. PfeiferL.A. WhiteL.R. RossG.W. PetrovitchH. LaunerL.J. Cerebral amyloid angiopathy and cognitive function.Neurology200258111629163410.1212/WNL.58.11.162912058090
     [Google Scholar]
  10. HaussmannR. HomeyerP. SauerC. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages—Prevalence and effects on cognition.Int. J. Geriatr. Psychiatry20233810601510.1002/gps.601537847104
     [Google Scholar]
  11. ArvanitakisZ. LeurgansS.E. WangZ. WilsonR.S. BennettD.A. SchneiderJ.A. Cerebral amyloid angiopathy pathology and cognitive domains in older persons.Ann. Neurol.201169232032710.1002/ana.2211221387377
     [Google Scholar]
  12. BoyleP.A. YuL. NagS. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.Neurology201585221930193610.1212/WNL.000000000000217526537052
     [Google Scholar]
  13. ReijmerY.D. FotiadisP. Martinez-RamirezS. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.Brain2015138117918810.1093/brain/awu31625367025
     [Google Scholar]
  14. XiongL. DavidsdottirS. ReijmerY.D. Cognitive profile and its association with neuroimaging markers of non-demented cerebral amyloid angiopathy patients in a stroke unit.J. Alzheimers Dis.201652117117810.3233/JAD‑15089027060947
     [Google Scholar]
  15. XiongL. van VeluwS.J. BounemiaN. Cerebral cortical microinfarcts on magnetic resonance imaging and their association with cognition in cerebral amyloid angiopathy.Stroke201849102330233610.1161/STROKEAHA.118.02228030355109
     [Google Scholar]
  16. CaseN.F. CharltonA. ZwiersA. Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment.Stroke20164782010201610.1161/STROKEAHA.116.01299927338926
     [Google Scholar]
  17. DurraniR. WangM. CoxE. Mediators of cognitive impairment in cerebral amyloid angiopathy.Int. J. Stroke2023181788410.1177/1747493022109935235473418
     [Google Scholar]
  18. VasquezB.P. ZakzanisK.K. The neuropsychological profile of vascular cognitive impairment not demented: A meta‐analysis.J. Neuropsychol.20159110913610.1111/jnp.1203924612847
     [Google Scholar]
  19. WeintraubS. WicklundA.H. SalmonD.P. The neuropsychological profile of Alzheimer disease.Cold Spring Harb. Perspect. Med.201224a00617110.1101/cshperspect.a00617122474609
     [Google Scholar]
  20. PlantonM. Saint-AubertL. RaposoN. High prevalence of cognitive impairment after intracerebral hemorrhage.PLoS One2017126017888610.1371/journal.pone.017888628570698
     [Google Scholar]
  21. SuboticA. McCrearyC.R. SaadF. Cortical thickness and its association with clinical cognitive and neuroimaging markers in cerebral amyloid angiopathy.J. Alzheimers Dis.20218141663167110.3233/JAD‑21013833998545
     [Google Scholar]
  22. van DortR. KaushikK. RasingI. Cognition in (pre)symptomatic dutch‐type hereditary and sporadic cerebral amyloid angiopathy.Alzheimers Dement.202420117518752810.1002/alz.1417139387105
     [Google Scholar]
  23. JoS. CheongE.N. KimN. Role of white matter abnormalities in the relationship between microbleed burden and cognitive impairment in cerebral amyloid angiopathy.J. Alzheimers Dis.202286266767810.3233/JAD‑21509435124637
     [Google Scholar]
  24. ValentiR. CharidimouA. XiongL. Visuospatial functioning in cerebral amyloid angiopathy: A pilot study.J. Alzheimers Dis.20175641223122710.3233/JAD‑16092728222510
     [Google Scholar]
  25. SuY. FuJ. ZhangY. XuJ. DongQ. ChengX. Visuospatial dysfunction is associated with posterior distribution of white matter damage in non‐demented cerebral amyloid angiopathy.Eur. J. Neurol.20212893113312010.1111/ene.1499334157199
     [Google Scholar]
  26. SchragM. KirshnerH. Neuropsychological effects of cerebral amyloid angiopathy.Curr. Neurol. Neurosci. Rep.20161687610.1007/s11910‑016‑0674‑127357378
     [Google Scholar]
  27. PlantonM. RaposoN. AlbucherJ.F. ParienteJ. Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern.Rev. Neurol.2017173956256510.1016/j.neurol.2017.09.00628993004
     [Google Scholar]
  28. SchiavolinS. CamardaG. MazzucchelliA. Cognitive and psychological characteristics in patients with cerebral amyloid angiopathy: A literature review.Neurol. Sci.20244573031304910.1007/s10072‑024‑07399‑738388894
     [Google Scholar]
  29. ChanE. BonifacioG.B. HarrisonC. Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.J. Neurol.2023270126124613210.1007/s00415‑023‑11977‑837672105
     [Google Scholar]
  30. BarucciE. SalvadoriE. MagiS. Cognitive profile in cerebral small vessel disease: Comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy.Sci. Rep.2024141592210.1038/s41598‑024‑55719‑w38467658
     [Google Scholar]
  31. HymanB.T. PhelpsC.H. BeachT.G. National institute on aging-alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease.Alzheimers Dement.20128111310.1016/j.jalz.2011.10.00722265587
     [Google Scholar]
  32. SchoemakerD. CharidimouA. ZotinZ.M.C. Association of memory impairment with concomitant tau pathology in patients with cerebral amyloid angiopathy.Neurology20219615e1975e198610.1212/WNL.000000000001174533627498
     [Google Scholar]
  33. TsaiH.H. LiuC.J. LeeB.C. Cerebral tau pathology in cerebral amyloid angiopathy.Brain Commun.202462fcae08610.1093/braincomms/fcae08638638152
     [Google Scholar]
  34. RabinJ.S. NicholsE. La JoieR. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.Brain202214582823283310.1093/brain/awac17835759327
     [Google Scholar]
  35. GodrichD. PasterisJ. MartinE.R. Cerebral amyloid angiopathy impacts neurofibrillary tangle burden and cognition.Brain Commun.202466fcae36910.1093/braincomms/fcae36939584156
     [Google Scholar]
  36. TheodorouA. AthanasakiA. MelanisK. Cognitive impairment in cerebral amyloid angiopathy: A single-center prospective cohort study.J. Clin. Med.20241323742710.3390/jcm1323742739685885
     [Google Scholar]
  37. De KortA.M. KaushikK. KuiperijH.B. The relation of a cerebrospinal fluid profile associated with Alzheimer’s disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy.Alzheimers Res. Ther.20241619910.1186/s13195‑024‑01454‑338704569
     [Google Scholar]
  38. RileyD.S. BarberM.S. KienleG.S. CARE guidelines for case reports: Explanation and elaboration document.J. Clin. Epidemiol.20178921823510.1016/j.jclinepi.2017.04.02628529185
     [Google Scholar]
  39. FabriziE. AncidoniA. LocuratoloN. The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment.Age Ageing20245311afae25010.1093/ageing/afae25039544104
     [Google Scholar]
  40. SalvadoriE. BrambillaM. CovaI. PomatiS. PantoniL. Cognitive evaluation in cerebral small vessel disease: towards an evidence-based identification of the reference standards. Part 1. A systematic review and qualitative data synthesis.J. Neurol.2021268124563457210.1007/s00415‑020‑10262‑233048216
     [Google Scholar]
  41. SalvadoriE. BrambillaM. MaestriG. The clinical profile of cerebral small vessel disease: Toward an evidence‐based identification of cognitive markers.Alzheimers Dement.202319124426010.1002/alz.1265035362229
     [Google Scholar]
  42. MagniE. BinettiG. BianchettiA. RozziniR. TrabucchiM. Mini‐mental state examination: A normative study in Italian elderly population.Eur. J. Neurol.19963319820210.1111/j.1468‑1331.1996.tb00423.x21284770
     [Google Scholar]
  43. CarlesimoG.A. CaltagironeC. GainottiG. The mental deterioration battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment.Eur. Neurol.199636637838410.1159/0001172978954307
     [Google Scholar]
  44. CostaA. BagojE. MonacoM. Standardization and normative data obtained in the Italian population for a new verbal fluency instrument, the phonemic/semantic alternate fluency test.Neurol. Sci.201435336537210.1007/s10072‑013‑1520‑823963806
     [Google Scholar]
  45. SicilianoM. ChiorriC. BattiniV. Regression-based normative data and equivalent scores for trail making test (TMT): An updated Italian normative study.Neurol. Sci.201940346947710.1007/s10072‑018‑3673‑y30535956
     [Google Scholar]
  46. CaffarraP. VezzadiniG. DieciF. ZonatoF. VenneriA. Una versione abbreviata del test di Stroop: Dati normativi nella popolazione italiana.Riv. Neurol.2002124111115
     [Google Scholar]
  47. MonacoM. CostaA. CaltagironeC. CarlesimoG.A. Erratum to: Forward and backward span for verbal and visuo-spatial data: Standardization and normative data from an Italian adult population.Neurol. Sci.201536234534710.1007/s10072‑014‑2019‑725491661
     [Google Scholar]
  48. AielloE.N. EspositoA. GramegnaC. The frontal assessment battery (FAB) and its sub-scales: Validation and updated normative data in an Italian population sample.Neurol. Sci.202243297998410.1007/s10072‑021‑05392‑y34184168
     [Google Scholar]
  49. CaffarraP. VezzadiniG. DieciF. ZonatoF. VenneriA. Rey-Osterrieth complex figure: Normative values in an Italian population sample.Neurol. Sci.200222644344710.1007/s10072020000311976975
     [Google Scholar]
  50. RicciM. RuggeriM. GnisciC. PizzoniL. GeraceC. BlundoC. Improving amnesia diagnostic accuracy with RAVLT single scores and composite indices: Italian normative data.Arch. Clin. Neuropsychol.20223781749176410.1093/arclin/acac05535870196
     [Google Scholar]
  51. ReyA. Rey auditory verbal learning test (RAVLT) L’Examen clinique en psychologie.ParisPresse Universitaires de France1964
     [Google Scholar]
  52. RicciM. GraefS. BlundoC. MillerL.A. Using the rey auditory verbal learning test (RAVLT) to differentiate Alzheimer’s dementia and behavioural variant fronto-temporal dementia.Clin. Neuropsychol.201226692694110.1080/13854046.2012.70407322809061
     [Google Scholar]
  53. VakilE. BlachsteinH. Rey auditory-verbal learning test: Structure analysis.J. Clin. Psychol.199349688389010.1002/1097‑4679(199311)49:6<883:AID‑JCLP2270490616>3.0.CO;2‑68300877
     [Google Scholar]
  54. LezakM.D. HowiesonD.B. BiglerE.D. TranelD. Neuropsychological Assessment.5th edNew YorkOxford University Press2012419426
     [Google Scholar]
  55. SpinnlerH. TognoniG. Italian standardization and calibration of neuropsychological tests.Ital. J. Neurol. Sci.198762527
     [Google Scholar]
  56. BennettI.J. GolobE.J. ParkerE.S. StarrA. Memory evaluation in mild cognitive impairment using recall and recognition tests.J. Clin. Exp. Neuropsychol.20062881408142210.1080/1380339050040958317050267
     [Google Scholar]
  57. GreenawayM.C. LacritzL.H. BinegarD. WeinerM.F. LiptonA. Munro CullumC. Patterns of verbal memory performance in mild cognitive impairment, Alzheimer disease, and normal aging.Cogn. Behav. Neurol.2006192798410.1097/01.wnn.0000208290.57370.a316783130
     [Google Scholar]
  58. WolkD.A. SignoffE.D. DeKoskyS.T. Recollection and familiarity in amnestic mild cognitive impairment: A global decline in recognition memory.Neuropsychologia20084671965197810.1016/j.neuropsychologia.2008.01.01718328509
     [Google Scholar]
  59. ChangY.L. BondiM.W. Fennema-NotestineC. Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer’s disease.Neuropsychologia20104851237124710.1016/j.neuropsychologia.2009.12.02420034503
     [Google Scholar]
  60. BalthazarM.L.F. YasudaC.L. CendesF. DamascenoB.P. Learning, retrieval, and recognition are compromised in aMCI and mild AD: Are distinct episodic memory processes mediated by the same anatomical structures?J. Int. Neuropsychol. Soc.201016120520910.1017/S135561770999095619835661
     [Google Scholar]
  61. RussoM.J. CohenG. CamposJ. Usefulness of discriminability and response bias indices for the evaluation of recognition memory in mild cognitive impairment and alzheimer disease.Dement. Geriatr. Cogn. Disord.2017431-211410.1159/00045225527889770
     [Google Scholar]
  62. RussoM.J. CamposJ. VázquezS. SevleverG. AllegriR.F. Adding recognition discriminability index to the delayed recall is useful to predict conversion from mild cognitive impairment to Alzheimer’s disease in the Alzheimer’s disease neuroimaging initiative.Front. Aging Neurosci.201794610.3389/fnagi.2017.0004628344552
     [Google Scholar]
  63. TomadessoC. de La SayetteV. de FloresR. Neuropsychology and neuroimaging profiles of amyloid‐positive versus amyloid‐negative amnestic mild cognitive impairment patients.Alzheimers Dement.201810126927710.1016/j.dadm.2018.02.00829780872
     [Google Scholar]
  64. De SimoneM.S. PerriR. FaddaL. CaltagironeC. CarlesimoG.A. Predicting progression to Alzheimer’s disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.J. Neurol.2019266110211110.1007/s00415‑018‑9108‑030386876
     [Google Scholar]
  65. GoldsteinF.C. LoringD.W. ThomasT. SalehS. HajjarI. Recognition memory performance as a cognitive marker of prodromal Alzheimer’s disease.J. Alzheimers Dis.201972250751410.3233/JAD‑19046831594225
     [Google Scholar]
  66. De SimoneM.S. LombardiM.G. De TollisM. Forgetting rate for the familiarity and recollection components of recognition in amnestic mild cognitive impairment: A longitudinal study.Appl. Neuropsychol. Adult20243161411142310.1080/23279095.2022.213544136264763
     [Google Scholar]
  67. DelisD.C. MassmanP.J. ButtersN. SalmonD.P. CermakL.S. KramerJ.H. Profiles of demented and amnesic patients on the California verbal learning test: Implications for the assessment of memory disorders.Psychol. Assess.199131192610.1037/1040‑3590.3.1.19
     [Google Scholar]
  68. ClarkL.R. StrickerN.H. LibonD.J. Yes/no versus forced-choice recognition memory in mild cognitive impairment and Alzheimer’s disease: Patterns of impairment and associations with dementia severity.Clin. Neuropsychol.20122671201121610.1080/13854046.2012.72862623030301
     [Google Scholar]
  69. WesterbergC. MayesA. FlorczakS.M. Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer’s disease.Neuropsychologia201351122450246110.1016/j.neuropsychologia.2013.06.02523831717
     [Google Scholar]
  70. CarusoG. PerriR. FaddaL. CaltagironeC. CarlesimoG.A. Recall and recognition in Alzheimer’s disease and frontotemporal dementia.J. Alzheimers Dis.202077265566610.3233/JAD‑20012632741812
     [Google Scholar]
  71. JuhlinF. MellqvistJ. EckerströmM. HellströmP. Rey auditory verbal learning test in idiopathic normal pressure hydrocephalus and Alzheimer’s disease.Clin. Neuropsychol.202438120221810.1080/13854046.2023.220097737051850
     [Google Scholar]
  72. LooiJ.C.L. SachdevP.S. Differentiation of vascular dementia from AD on neuropsychological tests.Neurology199953467067810.1212/WNL.53.4.67010489025
     [Google Scholar]
  73. SachdevP. KalariaR. O’BrienJ. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement.Alzheimer Dis. Assoc. Disord.201428320621810.1097/WAD.000000000000003424632990
     [Google Scholar]
  74. SekiM. YoshizawaH. HosoyaM. KitagawaK. Neuropsychological profile of early cognitive impairment in cerebral small vessel disease.Cerebrovasc. Dis.202251560060710.1159/00052243835378532
     [Google Scholar]
  75. GleichgerrchtE. TorralvaT. MartinezD. RocaM. ManesF. Impact of executive dysfunction on verbal memory performance in patients with Alzheimer’s disease.J. Alzheimers Dis.2011231798510.3233/JAD‑2010‑10099020930305
     [Google Scholar]
  76. ConsonniM. RossiS. CeramiC. Executive dysfunction affects word list recall performance: Evidence from amyotrophic lateral sclerosis and other neurodegenerative diseases.J. Neuropsychol.2017111749010.1111/jnp.1207225952058
     [Google Scholar]
  77. MelroseR.J. ZahniserE. WilkinsS.S. Prefrontal working memory activity predicts episodic memory performance: A neuroimaging study.Behav. Brain Res.202037911230710.1016/j.bbr.2019.11230731678217
     [Google Scholar]
  78. LibonD.J. DrabickD.A.G. GiovannettiT. Neuropsychological syndromes associated with Alzheimer’s/vascular dementia: A latent class analysis.J. Alzheimers Dis.2014423999101410.3233/JAD‑13214725024329
     [Google Scholar]
  79. HuH. WanS. HuY. WangQ. LiH. ZhangN. Deciphering the role of APOE in cerebral amyloid angiopathy: From genetic insights to therapeutic horizons.Ann. Med.2025571244519410.1080/07853890.2024.244519439745195
     [Google Scholar]
  80. DoranS.J. SawyerR.P. Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications.Front. Neurosci.202418132678410.3389/fnins.2024.132678438312931
     [Google Scholar]
/content/journals/car/10.2174/0115672050390451250808002719
Loading
Neuropsychological Aspects of Sporadic Cerebral Amyloid Angiopathy: A Case Series and Narrative Review
Curr Alzheimer Res 22, 613 (2025); https://doi.org/10.2174/0115672050390451250808002719
/content/journals/car/10.2174/0115672050390451250808002719
/content/journals/car/10.2174/0115672050390451250808002719
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Alzheimer’s disease; amyloid-β protein; Cerebral amyloid angiopathy; cerebral small vessel disease; cerebrovascular disorders; cognitive impairment; neuropsychological assessment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test